NVAX · NASDAQ · Biotechnology

Novavax (NVAX)

Builds protein vaccines and Matrix-M partnerships around Nuvaxovid and R21/Matrix-M.

$10.84
After hours+0.00 (+0.05%)
At close$10.84(+4.08%)